Author:
Keitner Gabor I.,Garlow Steven J.,Ryan Christine E.,Ninan Philip T.,Solomon David A.,Nemeroff Charles B.,Keller Martin B.
Subject
Biological Psychiatry,Psychiatry and Mental health
Reference46 articles.
1. Placebo controlled study of relapse prevention with rispendone augmentation in older patients with residual depression;Alexopoulos;American Journal of Geriatric Psychiatry,2008
2. Patients with severe depression may benefit from buspirone augmentation of selective serotonin reuptake inhibitors: results from a placebo-controlled, randomized, double-blind, placebo wash-in study;Appelberg;Journal of Clinical Psychiatry,2001
3. The effectiveness of olanzapine, risperidone, quetiapine, and ziprasidone as augmentation agents in treatment-resistant major depressive disorder;Barbee;Journal of Clinical Psychiatry,2004
4. The efficacy and safety of aripipraozle as adjunctive therapy in major depressive disorder: a multicenter, randomized double-blind placebo-controlled study;Berman;Journal of Clinical Psychiatry,2007
5. Potential mechanisms of action of atypical antipsychotic medications in treatment-resistant depression and anxiety;Blier;Journal of Clinical Psychiatry,2005
Cited by
88 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献